TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 380nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 490nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 530nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 530nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 660nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 8.20E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 8.80E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.12E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.45E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Goldfinch Bio Inc.
Curated by ChEMBL
Goldfinch Bio Inc.
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of rosiglitazone-activated human TRPC5 channel expressed in HEK293 cells assessed as reduction in Ca2+ current measured at +80 mV with hol...More data for this Ligand-Target Pair
